FREDERICK, Md. – A wearable by BioElectronics that manages chronic pain has been approved by the U.K.’s National Health Service and can now be prescribed by physicians there. The government-funded public health service has also agreed to reimbursement for the mHealth device, as well. “This is a major win for pain sufferers in the U.K., since they will now be able to obtain a prescription for ActiPatch, the cost of which will be covered by the government,” said Ian Rawe, director of clinical research at BioElectronics, in a statement. “We commend this move by the NHS, as this will open up the doors for reimbursement in the U.S. and other managed care markets.” The ActiPatch regulates peripheral nerve activity to provide pain relief. It was approved by the NHS based on clinical evidence and a health economics study, which found that the wearable significantly decreased pain and improved quality of life, while reducing overall health care costs by 42%. “This will likely have a tremendous impact on our sales and marketability of the product in the U.K. and elsewhere,” said Keith Nalepka, vice president of sales and marketing at BioElectronics, in a statement.
LONDON – Pfizer will work with startup companies Echo, Cera and GiveVision through its new Healthcare Hub initiative.
“We’re excited to be working with them over the next year as part of our wider program of digital innovation and look forward to seeing the impact of their technology on clinicians and patients,” said Dr. Berkeley Phillips, medical director at Pfizer UK, in a statement.
The health technology startups form the first cohort to be supported by the Pfizer Healthcare Hub: London, and will work with the biopharmaceutical giant to identify the areas that can most benefit from support over the next 12 months. The ultimate goal of the program is to help the startups get their technology adopted in the National Health Service within a year.
The start-ups will have access to Pfizer’s network of partners who share the goal of improving experiences for doctors and outcomes for patients.
Echo is a free app that lets users order NHS prescriptions and medications, and have them delivered at their home; Cera is a technology-enabled home care provider that uses automatic matching, online care reports and other technologies to help keep elderly people living at home; and GiveVision makes a wearable headset to help improve vision for certain forms of visual impairment.